Towards clinical translation of new gene targeting technologies for correcting inherited mutations and empowering adoptive immunotherapy of cancer

Project Information

SUPERSIST

Grant agreement ID: 601958

Project closed

Start date 1 May 2013

End date 31 October 2016

Funded under

• Specific Programme "Cooperation": Health

Total cost € 7 892 920,36

EU contribution € 5 999 997,00

Coordinated by

UNIVERSITA VITA-SALUTE SAN RAFFAELE
Italy